Loading organizations...
Loading organizations...
Develops topical antiseptics, anti-infectives, and intranasal vaccines.
BlueWillow Biologics has raised $21.0M across 2 funding rounds.
BlueWillow Biologics has raised $21.0M in total across 2 funding rounds.
BlueWillow Biologics has raised $21.0M in total across 2 funding rounds.
BlueWillow Biologics's investors include Line Moon Ventures, North Coast Technology Investors, University of Michigan.
BlueWillow Biologics has raised $21.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 7, 2018 | $10.0M Series A | Line Moon Ventures, North Coast Technology Investors, University of Michigan | |
| Nov 28, 2012 | $11.0M Series C |